Psoriatic Arthritis Therapeutics Market Size, Share and Forecast 2026
The Psoriatic Arthritis Therapeutics Market was worth USD XXXX million in 2018 and is forecasted to reach USD XXXX million by 2026, at a CAGR of XX% during the forecast period.
(EMAILWIRE.COM, September 16, 2019 ) Market Overview:
Large patient population is suffering from moderate to severe psoriatic arthritis with unmet medical needs, and the number is increasing across the globe. This disease falls in the progressive category of diseases that may get worse over time. If left untreated, psoriatic arthritis may lead to joint damage permanently due to the degeneration of the cartilages present in the joints. Treatment of psoriatic arthritis involves the use of biologic drugs, enzyme inhibitors, disease-modifying rheumatoid arthritis drugs, and nonsteroidal anti-inflammatory drugs. Several drugs are into clinical testing which depicts the possibility of discovering new molecules with maximum activity and minimum side effects.
Market Dynamics:
The market is driven by an increase in the prevalence of psoriatic arthritis, new product development, rise in adoption of biologics for the treatment of moderate to severe psoriatic arthritis and large patient population with unmet medical needs across the globe. The high cost of the drugs, generic erosion and treatment and lack of standardization tools for diagnosis and treatment are going to restrain the market in the forecast period.
Market Segmentation:
By Drug Class
• Nonsteroidal anti-inflammatory drug (NSAID)
• Disease-modifying antirheumatic drug (DMARD)
• Biologic drugs
By Route of Administration
• Oral
• Parenteral
• Topical
By Distribution Channel
• Hospital pharmacies
• Retail pharmacies
• Online pharmacies
Geographical Analysis:
By Geography, the market is segmented into:
• North America
• Europe
• South America
• Asia Pacific
• The Middle East and Africa
Competitive Analysis:
Key Players:
• AbbVie, Inc.*
• Janssen Biotech, Inc.
• Novartis AG
• Amgen, Inc.
• Celgene Corporation
• Pfizer, Inc.
• Others
View full report: https://www.datamintelligence.com/research-report/psoriatic-arthritis-therapeutics-market
Download free sample: https://www.datamintelligence.com/download-sample/psoriatic-arthritis-therapeutics-market
About Us:
DataM Intelligence was incorporated in the early weeks of 2017 as a Market Research and Consulting firm with just two people on board. Within a span of less than a year we have secured more than 100 unique customers from established organizations all over the world.
For more information:
Sai Kiran
Sales Manager at Data M Intelligence
Email: info@datamintelligence.com
Tel: +1 877 441 4866
Website: www.datamintelligence.com
Large patient population is suffering from moderate to severe psoriatic arthritis with unmet medical needs, and the number is increasing across the globe. This disease falls in the progressive category of diseases that may get worse over time. If left untreated, psoriatic arthritis may lead to joint damage permanently due to the degeneration of the cartilages present in the joints. Treatment of psoriatic arthritis involves the use of biologic drugs, enzyme inhibitors, disease-modifying rheumatoid arthritis drugs, and nonsteroidal anti-inflammatory drugs. Several drugs are into clinical testing which depicts the possibility of discovering new molecules with maximum activity and minimum side effects.
Market Dynamics:
The market is driven by an increase in the prevalence of psoriatic arthritis, new product development, rise in adoption of biologics for the treatment of moderate to severe psoriatic arthritis and large patient population with unmet medical needs across the globe. The high cost of the drugs, generic erosion and treatment and lack of standardization tools for diagnosis and treatment are going to restrain the market in the forecast period.
Market Segmentation:
By Drug Class
• Nonsteroidal anti-inflammatory drug (NSAID)
• Disease-modifying antirheumatic drug (DMARD)
• Biologic drugs
By Route of Administration
• Oral
• Parenteral
• Topical
By Distribution Channel
• Hospital pharmacies
• Retail pharmacies
• Online pharmacies
Geographical Analysis:
By Geography, the market is segmented into:
• North America
• Europe
• South America
• Asia Pacific
• The Middle East and Africa
Competitive Analysis:
Key Players:
• AbbVie, Inc.*
• Janssen Biotech, Inc.
• Novartis AG
• Amgen, Inc.
• Celgene Corporation
• Pfizer, Inc.
• Others
View full report: https://www.datamintelligence.com/research-report/psoriatic-arthritis-therapeutics-market
Download free sample: https://www.datamintelligence.com/download-sample/psoriatic-arthritis-therapeutics-market
About Us:
DataM Intelligence was incorporated in the early weeks of 2017 as a Market Research and Consulting firm with just two people on board. Within a span of less than a year we have secured more than 100 unique customers from established organizations all over the world.
For more information:
Sai Kiran
Sales Manager at Data M Intelligence
Email: info@datamintelligence.com
Tel: +1 877 441 4866
Website: www.datamintelligence.com
Contact Information:
DataM Intelligence
Sai Kiran
Tel: +1 877 441 4866
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results
DataM Intelligence
Sai Kiran
Tel: +1 877 441 4866
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results